D.E. Low Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Figure 1. Percentage of Penicillin Non-Susceptible S

Laboratory diagnosis and biosafety issues of biological warfare agents

R. Leclercq Clinical Microbiology and Infection

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

G. Cornaglia, A. Lönnroth, M. Struelens

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Gut bacterial microbiota and obesity

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii X. Vila-Farres, C. Garcia.

Evolution of extended-spectrum β-lactamases by mutation

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

Quinolone resistance among Shigella spp

R. Cantón Clinical Microbiology and Infection

Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media Fernando Baquero, Rafael Cantón, Fernando.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

Carriage and antibiotic resistance of respiratory pathogens and molecular epidemiology of antibiotic-resistant Streptococcus pneumoniae colonizing children.

Clinical Microbiology and Infection

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System M.E.A. de Kraker, V. Jarlier,

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Keith Klugman, Fred Goldstein,

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern.

Sofie Arens, Jan Verhaegen, Ludo Verbist

E.C. Böttger Clinical Microbiology and Infection

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Bacterial resistance—the clinical challenge

M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A

Prevalence of Streptococcus pneumoniae isolates bearing macrolide resistance genes in association with integrase genes of conjugative transposons in Japan

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Percentage of Penicillin Non-Susceptible S

Levofloxacin in the treatment of ventilator-associated pneumonia

Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region K.B. Laupland, M.D. Parkins, T. Ross, J.D.D. Pitout

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

M. Aires-de-Sousa Clinical Microbiology and Infection

L. Arreaza, J.A. Vázquez Clinical Microbiology and Infection

Figure 1. Percentage of Penicillin Non-Susceptible S

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

D. Felmingham, C. Feldman, W. Hryniewicz, K. Klugman, S. Kohno, D. E

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Can β-lactams be re-engineered to beat MRSA?

P.M. Hawkey Clinical Microbiology and Infection

C. Oprica, C.E. Nord Clinical Microbiology and Infection

Reducing antibiotic use in influenza: challenges and rewards

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

C. Gagliotti, L. Nobilio, M.L. Moro

The prevalence of penicillin-non-susceptible Streptococcus pneumoniae among children aged < 5 years correlates with the biannual epidemic activity of.

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin G. Drusano Clinical Microbiology and Infection

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

M. Biçmen, Z. Gülay, S.V. Ramaswamy, D.M. Musher, D. Gür

Modification of prescribers’ behavior: the Icelandic approach

B.A. Cunha Clinical Microbiology and Infection

European recommendations for antimicrobial resistance surveillance

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Fernando Baquero, John F

The future of diagnostic bacteriology

Presentation transcript:

The era of antimicrobial resistance—implications for the clinical laboratory D.E. Low Clinical Microbiology and Infection Volume 8, Pages 9-20 (January 2002) DOI: 10.1046/j.1469-0691.8.s.3.2.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Macrolide resistance among Streptococcus pneumoniae isolates from various countries (resistance defined as erythromycin MIC ≥1 mg/L). Alexander Project 2000. data on file—GlaxoSmithKline (manuscript in preparation) Clinical Microbiology and Infection 2002 8, 9-20DOI: (10.1046/j.1469-0691.8.s.3.2.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Distribution of erythromycin resistance phenotypes among 249 strains of erythromycin-resistant Streptococcus pneumoniae. collected by the Canadian Bacterial Surveillance Network from across Canada in 2000 Clinical Microbiology and Infection 2002 8, 9-20DOI: (10.1046/j.1469-0691.8.s.3.2.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Penicillin resistance among isolates of Streptococcus pneumoniae isolates from various countries. Alexander Project 2000, data on file—GlaxoSmithKline (manuscript in preparation). Clinical Microbiology and Infection 2002 8, 9-20DOI: (10.1046/j.1469-0691.8.s.3.2.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 4 Association between fluoroquinolone prescriptions per capita and percentage of pneumococci with reduced susceptibility to fluoroquinolones in Canada in two age groups. Solid bars represent 15–64-year age group; open bars represent > 65-year age group. Reproduced from Chen et al. [42] with permission. Clinical Microbiology and Infection 2002 8, 9-20DOI: (10.1046/j.1469-0691.8.s.3.2.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions